5th HIV Persistence Workshop on HIV Reservoirs, 6-9 December 2011, West Indies
1 February 2012. Related: Conference reports, Cure-related research, Basic science and immunology, Virology.
Conference reports
Workshop report and commentary: HIV persistence and reservoirs
1 February 2012. Related: Conference reports, Cure-related research, Basic science and immunology, Virology.
13th European AIDS Conference (EACS), Belgrade, Serbia, 12-15 October 2011
1 December 2011. Related: Conference reports.
European guidelines (EACS) – 2011 update
1 December 2011. Related: Conference reports, Guidelines.
Raltegravir achieves superiority over efavirenz after four years
1 December 2011. Related: Conference reports, Antiretrovirals.
Higher plasma levels of tenofovir and darunavir but not efavirenz in older patients
1 December 2011. Related: Conference reports, PK and drug interactions.
Ritonavir levels reduced with high fat meal
1 December 2011. Related: Conference reports, PK and drug interactions, Nutrition.
Transplacental transfer of raltegravir and delayed plasma clearance in preterm neonates
1 December 2011. Related: Conference reports, Pregnancy.
2nd International Workshop on HIV and Ageing, Baltimore, Maryland, 27-28 October 2011
1 December 2011. Related: Conference reports.
Statin blocks negative impact of PIs on bone formation in vitro
1 December 2011. Related: Conference reports, Antiretrovirals.
HIV linked to frailty in middle-aged IDUs, especially with poor HIV control
1 December 2011. Related: Conference reports, Coinfections and complications.
51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Chicago, 17-20 September 2011
1 December 2011. Related: Conference reports.
Monitoring kidney function change with cobicistat
1 December 2011. Related: Conference reports, PK and drug interactions.
Intracellular raltegravir concentrations better with twice-daily than once-daily dosing
1 December 2011. Related: Conference reports, Antiretrovirals.
6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 17-20 July 2011, Rome
1 October 2011. Related: Conference reports.
Cure research and viral reservoirs
1 October 2011. Related: Conference reports, Cure-related research, Basic science and immunology.
Orange Farm circumcision results dispel concerns about risk compensation
1 October 2011. Related: Conference reports, HIV prevention and transmission.
Randomised trial of ART in TB patients with high CD4 counts
1 October 2011. Related: Conference reports, TB coinfection.
6th IAS Conference on HIV Pathogenesis, Treatment and Prevention 17-20 July 2011, Rome
1 August 2011. Related: Conference reports.
Webcasts for major research at IAS
1 August 2011. Related: Conference reports.
Treatment is prevention: ARV treatment in HPTN-052 reduces transmission by at least 96%: single transmission in treatment arm occurred before viral suppression
1 August 2011. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Daily oral tenofovir/FTC PrEP reduces heterosexual transmission by 63% in the TDF2 study
1 August 2011. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Tenofovir/FTC vs tenofovir as daily oral PrEP: preliminary results from Partners PrEP
1 August 2011. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Elvitegravir vs raltegravir: 48 week results in treatment-experienced patients
1 August 2011. Related: Conference reports, Antiretrovirals.
Dolutegravir: 48 week results from phase II study in treatment-naive patients
1 August 2011. Related: Conference reports, Antiretrovirals.
Lersivirine: 48 week results compared to efavirenz in phase 2 treatment-naive study
1 August 2011. Related: Conference reports, Antiretrovirals.
Maraviroc plus atazanavir/r without nukes versus standard of care: 48 week results
1 August 2011. Related: Conference reports, Antiretrovirals.
SPARTAC trial: treatment in primary infection for 48 weeks shows small delay in disease progression
1 August 2011. Related: Conference reports, Antiretrovirals.
Hearing loss not associated with HIV in MACS and WIHS cohorts
1 August 2011. Related: Conference reports, Side effects, Coinfections and complications.
Pharmacokinetics of darunavir and fosamprenavir in pregnancy
1 August 2011. Related: Conference reports, Pregnancy, PK and drug interactions.
Low birth weight and preterm delivery
1 August 2011. Related: Conference reports, Pregnancy.
Hormonal contraception and HIV transmission risk
1 August 2011. Related: Conference reports, Pregnancy.
No difference in AIDS-free survival in children starting ART with a CD4% between 15%24% compared to deferring until less than 15% in the PREDICT trial
1 August 2011. Related: Conference reports, Paediatric care.
Paediatric antiretroviral pipeline: update on etravirine and maraviroc
1 August 2011. Related: Conference reports, Paediatric care.
Prematurity not associated with early mortality in infants on ART
1 August 2011. Related: Conference reports, Paediatric care.
More metabolic abnormalities in children receiving a PI compared to NNRTI in NEVEREST study
1 August 2011. Related: Conference reports, Paediatric care, Side effects.
Free online resource for treatment decisions without access to genotype resistance tests
1 August 2011. Related: Conference reports, Drug resistance.
17th Annual Conference of the British HIV Association (BHIVA) 6-8 April 2011, Bournemouth
1 August 2011. Related: Conference reports.
Treatment in seroconversion maintains HIV specific immune responses similar to long term slow progressors
1 August 2011. Related: Conference reports, Treatment strategies, Basic science and immunology.
18th Conference on Retroviruses and Opportunistic Infections (CROI) 27 February-3 March 2011, Boston
1 August 2011. Related: Conference reports.
Monitoring treatment in resource limited settings: results from PHPT-3 and Stratall ANRS12110/ESTER trials
1 August 2011. Related: Conference reports, Treatment strategies, Treatment access.
DART: high rates of viral suppression after five years and a single CD4 test with a threshold of 250 cells/mm3 could reduce unnecessary switching
1 August 2011. Related: Conference reports, Treatment strategies, Treatment access.
Lopinavir/r monotherapy used as second-line therapy in resource-limited settings
1 August 2011. Related: Conference reports, Treatment strategies, Treatment access.
Treating children previously exposed to single dose nevirapine: update on IMPAACT P1060 and NEVEREST
1 August 2011. Related: Conference reports, Pregnancy, Paediatric care.
Lopinavir/ritonavir oral solution toxicity in neonates
1 August 2011. Related: Conference reports, Paediatric care, Side effects.
Paediatric antiretroviral pipeline: darunavir and raltegravir
1 August 2011. Related: Conference reports, Antiretrovirals, Paediatric care.
Pharmacokinetics of different rifabutin dosing strategies with lopinavir/ritonavir-based ART
1 August 2011. Related: Conference reports, PK and drug interactions, TB coinfection.
Initiation of ART during breastfeeding can induce multidrug resistance in infants
1 August 2011. Related: Conference reports, Pregnancy.
First Workshop on Nanomedicine for Infectious Diseases of Poverty, 27-31 March 2011, Magaliesberg, South Africa
10 May 2011. Related: Conference reports.
17th Annual Conference of the British HIV Association (BHIVA), 6-8 April 2011, Bournemouth
1 May 2011. Related: Conference reports.
Atazanavir in pregnancy: 155 cases in London clinics
1 May 2011. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
Co-morbidity and late presentation – findings from an over 50s cohort
1 May 2011. Related: Conference reports.
Health outcomes for young adults with perinatally acquired HIV infection following transfer to adult services
1 May 2011. Related: Conference reports, Paediatric care.
The use of calcaneal stiffness index to screen for osteoporosis in HIV-infected individuals
1 May 2011. Related: Conference reports.
Frequency and characteristics of long-term non-progressors and HIV controllers in the Chelsea and Westminster cohort
1 May 2011. Related: Conference reports.
Cerebral function in perinatally HIV infected young people and HIV uninfected sibling controls
1 May 2011. Related: Conference reports.
An audit of HIV care provision for Immigration Removal Centre patients
1 May 2011. Related: Conference reports, Treatment access.
12th International Workshop on Clinical Pharmacology of HIV Therapy, 13-15 April 2011, Miami
1 May 2011. Related: Conference reports.
Quad reduces levels of oral contraceptives
1 May 2011. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Elvitegravir/cobicistat and acid reducing agents
1 May 2011. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Lopinavir/r reduces levels of rifabutin
1 May 2011. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Cobicistat has little impact on CYP2D6 and CYP2B6
1 May 2011. Related: Conference reports, Antiretrovirals.
Atazanavir levels indicate need for higher dose during pregnancy
1 May 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
Etravirine lowers levels of maraviroc given at 300 or 600 mg twice daily
1 May 2011. Related: Conference reports, Antiretrovirals.
Once-daily 150-mg maraviroc explored in people taking atazanavir/ritonavir
1 May 2011. Related: Conference reports, Antiretrovirals.